Sisal-Hem Pharmaceutical Private Limited
About Sisal-Hem Pharmaceutical Private Limited
Data last updated:
Sisal-Hem Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2015PTC264557. Its GSTIN is 27AAVCS7868N1ZY (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Supriya Sanjay Mane and Pratik Prakash Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 2 – 2. Plot 12 Sector 17 Mumbai Co. Op. Hsg Socity Vashi, Maharashtra, India – 400703.
As per the financials filed for FY 2017, the company reported a revenue of ₹38.97 Lakh. For the same year it recorded a net loss of ₹43.87 Lakh (net margin -112.6%) and EBITDA of -₹43.66 Lakh (EBITDA margin -112%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sisal-Hem Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 2 – 2. Plot 12 Sector 17 Mumbai Co. Op. Hsg Socity Vashi, Maharashtra, India – 400703
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sisal-Hem Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sisal-Hem Pharmaceutical Private Limited
FY 2025 filings availableSisal-Hem Pharmaceutical Private Limited reported revenue of ₹38.97 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹38.97 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹43.66 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹43.87 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -112% | |
| Net Profit Margin | -112.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sisal-Hem Pharmaceutical Private Limited, buy the company report.
Board of directors of Sisal-Hem Pharmaceutical Private Limited
Sisal-Hem Pharmaceutical has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Supriya Sanjay Mane | Director | 16 May 2015 | 11 Years 5 Months | Current |
| Pratik Prakash Patil | Director | 11 May 2018 | 8 Years 5 Months | Current |
| Abhilash Prakash Patil | Director | 16 May 2015 | 11 Years 5 Months | Current |
| Pruthviraj Navin Khodave | Director | 06 Dec 2025 | 0 Years 10 Months | Current |
Auditor
Sisal-Hem Pharmaceutical Private Limited is audited by GIRISH ASHOKLAL PANJWANI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GIRISH ASHOKLAL PANJWANI | FY 2017 | 65925 |
Shareholding
The shareholding of Sisal-Hem Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sisal-Hem Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sisal-Hem Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sisal-Hem Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sisal-Hem Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVCS7868N1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sisal-Hem Pharmaceutical Private Limited, buy the company report.
Recent activity
Sisal-Hem Pharmaceutical Private Limited has 9 board changes on record since 2015: 4 appointments and 5 cessations. The latest: Pruthviraj Navin Khodave was appointed as Director on 06 Dec 2025.
Frequently asked questions
Sisal-Hem Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2015 (11+ years old) and is registered under CIN U74900MH2015PTC264557.
Sisal-Hem Pharmaceutical has 4 current directors:
- Supriya Sanjay Mane - Director
- Pratik Prakash Patil - Director
- Abhilash Prakash Patil - Director
- Pruthviraj Navin Khodave - Director
The latest financial statements of Sisal-Hem Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sisal-Hem Pharmaceutical is 27AAVCS7868N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sisal-Hem Pharmaceutical is U74900MH2015PTC264557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sisal-Hem Pharmaceutical was incorporated on 16 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Pruthviraj Navin Khodave was appointed as Director on 06 Dec 2025. Sagar Bapuso Nichite ceased to be Additional Director on 30 Nov 2021. Prakash Sarjerao Patil ceased to be Additional Director on 29 Sep 2018. Sisal-Hem Pharmaceutical has 9 board changes on record in total.
The registered office of Sisal-Hem Pharmaceutical is at C – 2 – 2. Plot 12 Sector 17 Mumbai Co. Op. Hsg Socity Vashi, Maharashtra, India – 400703.
Sisal-Hem Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sisal-Hem Pharmaceutical is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
